X4 Pharmaceuticals, Inc. (XFOR) Q4 2024 Earnings Call Transcript
…
0,190$
1,60%
Echtzeit-Aktienkurs X4 Pharmaceuticals Inc
Bid:
Ask:
Nachrichten zur X4 Pharmaceuticals Inc Aktie
X4 Pharmaceuticals, Inc. (XFOR) Q2 2024 Earnings Call Transcript
…
X4 Pharmaceuticals: Catch The Falling Knife After Propitious Mavorixafor Data
…
X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
$125 million of non-dilutive capital extends projected cash runway into late 2025, excluding expected commercial sales from XOLREMDI™ (mavorixafor)…
X4 Pharmaceuticals Inc (XFOR) Q1 2024 Earnings Call Transcript
…
X4 Pharmaceuticals: FDA Approval For WHIM Warrants Further Upside
…
X4 Pharmaceuticals: PDUFA Excitement Ahead
…
NRX Pharmaceuticals, Inc. (NRXP) Q4 2023 Earnings Call Transcript
…
X4 Pharmaceuticals, Inc. (XFOR) Q4 2023 Earnings Call Transcript
…
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, March 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives…